{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:57:53Z","timestamp":1791482273245,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL132071"],"award-info":[{"award-number":["R01HL132071"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL123904"],"award-info":[{"award-number":["R01HL123904"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41375-020-1002-y","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T11:05:33Z","timestamp":1596539133000},"page":"1108-1120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Complex landscape of alternative splicing in myeloid neoplasms"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2195-989X","authenticated-orcid":false,"given":"Courtney E.","family":"Hershberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devlin C.","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Adema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra M.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencke","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Hutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manja","family":"Meggendorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niroshan","family":"Nadarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Twardziok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2910-1134","authenticated-orcid":false,"given":"Richard A.","family":"Padgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011;478:64\u20139.","journal-title":"Nature"},{"key":"1002_CR2","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood-2011-12-399774","volume":"119","author":"H Makishima","year":"2012","unstructured":"Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 2012;119:3203\u201310.","journal-title":"Blood"},{"key":"1002_CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2014;28:241\u20137.","journal-title":"Leukemia"},{"key":"1002_CR4","volume":"6","author":"V Madan","year":"2015","unstructured":"Madan V, Kanojia D, Li J, Okamoto R, Sato-Otsubo A, Kohlmann A, et al. Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nat Commun. 2015;6:6042.","journal-title":"Nat Commun."},{"key":"1002_CR5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","volume":"27","author":"C Polprasert","year":"2015","unstructured":"Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N, et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer cell 2015;27:658\u201370.","journal-title":"Cancer cell"},{"key":"1002_CR6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/leu.2014.144","volume":"29","author":"A Kurtovic-Kozaric","year":"2015","unstructured":"Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK, et al. PRPF8 defects cause missplicing in myeloid malignancies. Leukemia 2015;29:126\u201336.","journal-title":"Leukemia"},{"key":"1002_CR7","unstructured":"Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122:3616\u201327. quiz 99."},{"key":"1002_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-019-1618-0","volume":"574","author":"A Yoshimi","year":"2019","unstructured":"Yoshimi A, Lin KT, Wiseman DH, Rahman MA, Pastore A, Wang B, et al. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. Nature. 2019;574:273\u20137.","journal-title":"Nature"},{"key":"1002_CR9","doi-asserted-by":"crossref","first-page":"D132","DOI":"10.1093\/nar\/gks999","volume":"41","author":"I Cvitkovic","year":"2013","unstructured":"Cvitkovic I, Jurica MS. Spliceosome database: a tool for tracking components of the spliceosome. Nucleic Acids Res. 2013;41:D132\u201341.","journal-title":"Nucleic Acids Res."},{"key":"1002_CR10","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1101\/gad.12.10.1409","volume":"12","author":"C Wang","year":"1998","unstructured":"Wang C, Chua K, Seghezzi W, Lees E, Gozani O, Reed R. Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev. 1998;12:1409\u201314.","journal-title":"Genes Dev."},{"key":"1002_CR11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/45590","volume":"402","author":"S Wu","year":"1999","unstructured":"Wu S, Romfo CM, Nilsen TW, Green MR. Functional recognition of the 3\u2019 splice site AG by the splicing factor U2AF35. Nature 1999;402:832\u20135.","journal-title":"Nature"},{"key":"1002_CR12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nsmb.2906","volume":"21","author":"C Shao","year":"2014","unstructured":"Shao C, Yang B, Wu T, Huang J, Tang P, Zhou Y, et al. Mechanisms for U2AF to define 3\u2019 splice sites and regulate alternative splicing in the human genome. Nat Struct Mol Biol. 2014;21:997\u20131005.","journal-title":"Nat Struct Mol Biol."},{"key":"1002_CR13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/MCB.20.3.1063-1071.2000","volume":"20","author":"HX Liu","year":"2000","unstructured":"Liu HX, Chew SL, Cartegni L, Zhang MQ, Krainer AR. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions. Mol Cell Biol. 2000;20:1063\u201371.","journal-title":"Mol Cell Biol."},{"key":"1002_CR14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/emboj.2011.367","volume":"31","author":"GM Daubner","year":"2012","unstructured":"Daubner GM, Clery A, Jayne S, Stevenin J, Allain FH. A syn-anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well. Embo J. 2012;31:162\u201374.","journal-title":"Embo J."},{"key":"1002_CR15","doi-asserted-by":"publisher","first-page":"E4726","DOI":"10.1073\/pnas.1514105112","volume":"112","author":"J Zhang","year":"2015","unstructured":"Zhang J, Lieu YK, Ali AM, Penson A, Reggio KS, Rabadan R, et al. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. Proc Natl Acad Sci USA 2015;112:E4726\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1002_CR16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.celrep.2015.09.053","volume":"13","author":"RB Darman","year":"2015","unstructured":"Darman RB, Seiler M, Agrawal AA, Lim KH, Peng S, Aird D, et al. Cancer-associated SF3B1 hotspot mutations induce Cryptic 3\u2019 splice site selection through use of a different branch point. Cell Rep. 2015;13:1033\u201345.","journal-title":"Cell Rep."},{"key":"1002_CR17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/leu.2014.331","volume":"29","author":"H Dolatshad","year":"2015","unstructured":"Dolatshad H, Pellagatti A, Fernandez-Mercado M, Yip BH, Malcovati L, Attwood M, et al. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Leukemia 2015;29:1092\u2013103.","journal-title":"Leukemia"},{"key":"1002_CR18","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1038\/leu.2016.149","volume":"30","author":"H Dolatshad","year":"2016","unstructured":"Dolatshad H, Pellagatti A, Liberante FG, Llorian M, Repapi E, Steeples V, et al. Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes. Leukemia 2016;30:2322\u201331.","journal-title":"Leukemia"},{"key":"1002_CR19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/onc.2016.279","volume":"36","author":"AK Kesarwani","year":"2017","unstructured":"Kesarwani AK, Ramirez O, Gupta AK, Yang X, Murthy T, Minella AC, et al. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3\u2019 splice sites within RNA secondary structures. Oncogene 2017;36:1123\u201333.","journal-title":"Oncogene"},{"key":"1002_CR20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","volume":"27","author":"E Kim","year":"2015","unstructured":"Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramakrishnan A, et al. SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell 2015;27:617\u201330.","journal-title":"Cancer Cell"},{"key":"1002_CR21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1101\/gr.181016.114","volume":"25","author":"JO Ilagan","year":"2015","unstructured":"Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, et al. U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Res. 2015;25:14\u201326.","journal-title":"Genome Res."},{"key":"1002_CR22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06063-x","volume":"9","author":"Y Shiozawa","year":"2018","unstructured":"Shiozawa Y, Malcovati L, Galli A, Sato-Otsubo A, Kataoka K, Sato Y, et al. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. Nat Commun. 2018;9:3649.","journal-title":"Nat Commun."},{"key":"1002_CR23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41556-019-0314-5","volume":"21","author":"MA Smith","year":"2019","unstructured":"Smith MA, Choudhary GS, Pellagatti A, Choi K, Bolanos LC, Bhagat TD, et al. U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies. Nat Cell Biol. 2019;21:640\u201350.","journal-title":"Nat Cell Biol."},{"key":"1002_CR24","doi-asserted-by":"crossref","first-page":"e87361","DOI":"10.1371\/journal.pone.0087361","volume":"9","author":"AN Brooks","year":"2014","unstructured":"Brooks AN, Choi PS, de Waal L, Sharifnia T, Imielinski M, Saksena G, et al. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PloS ONE 2014;9:e87361.","journal-title":"PloS ONE"},{"key":"1002_CR25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood-2017-01-762393","volume":"131","author":"A Kon","year":"2018","unstructured":"Kon A, Yamazaki S, Nannya Y, Kataoka K, Ota Y, Nakagawa MM, et al. Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice. Blood 2018;131:621\u201335.","journal-title":"Blood"},{"key":"1002_CR26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2016.08.006","volume":"30","author":"EA Obeng","year":"2016","unstructured":"Obeng EA, Chappell RJ, Seiler M, Chen MC, Campagna DR, Schmidt PJ, et al. Physiologic expression of Sf3b1(K700E) causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation. Cancer Cell 2016;30:404\u201317.","journal-title":"Cancer Cell"},{"key":"1002_CR27","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/leu.2016.251","volume":"31","author":"A Mupo","year":"2017","unstructured":"Mupo A, Seiler M, Sathiaseelan V, Pance A, Yang Y, Agrawal AA, et al. Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts. Leukemia 2017;31:720\u20137.","journal-title":"Leukemia"},{"key":"1002_CR28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccell.2015.04.008","volume":"27","author":"CL Shirai","year":"2015","unstructured":"Shirai CL, Ley JN, White BS, Kim S, Tibbitts J, Shao J, et al. Mutant U2AF1 expression alters hematopoiesis and Pre-mRNA Splicing In Vivo. Cancer Cell 2015;27:631\u201343.","journal-title":"Cancer Cell"},{"key":"1002_CR29","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1172\/JCI96202","volume":"127","author":"BH Yip","year":"2017","unstructured":"Yip BH, Steeples V, Repapi E, Armstrong RN, Llorian M, Roy S, et al. The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes. J Clin Investig. 2017;127:3557.","journal-title":"J Clin Investig."},{"key":"1002_CR30","doi-asserted-by":"crossref","first-page":"E10437","DOI":"10.1073\/pnas.1812669115","volume":"115","author":"DL Fei","year":"2018","unstructured":"Fei DL, Zhen T, Durham B, Ferrarone J, Zhang T, Garrett L, et al. Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1. Proc Natl Acad Sci USA 2018;115:E10437\u2013e46.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1002_CR31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ccell.2015.04.007","volume":"27","author":"S Colla","year":"2015","unstructured":"Colla S, Ong DS, Ogoti Y, Marchesini M, Mistry NA, Clise-Dwyer K, et al. Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome. Cancer Cell 2015;27:644\u201357.","journal-title":"Cancer Cell"},{"key":"1002_CR32","doi-asserted-by":"crossref","first-page":"e1004105","DOI":"10.1371\/journal.pcbi.1004105","volume":"11","author":"C DeBoever","year":"2015","unstructured":"DeBoever C, Ghia EM, Shepard PJ, Rassenti L, Barrett CL, Jepsen K, et al. Transcriptome sequencing reveals potential mechanism of cryptic 3\u2019 splice site selection in SF3B1-mutated cancers. PLoS Comput Biol. 2015;11:e1004105.","journal-title":"PLoS Comput Biol."},{"key":"1002_CR33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/leu.2011.232","volume":"26","author":"V Visconte","year":"2012","unstructured":"Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, et al. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 2012;26:542\u20135.","journal-title":"Leukemia"},{"key":"1002_CR34","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2013-01-480970","volume":"122","author":"B Przychodzen","year":"2013","unstructured":"Przychodzen B, Jerez A, Guinta K, Sekeres MA, Padgett R, Maciejewski JP, et al. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Blood 2013;122:999\u20131006.","journal-title":"Blood"},{"key":"1002_CR35","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","volume":"365","author":"E Papaemmanuil","year":"2011","unstructured":"Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365:1384\u201395.","journal-title":"N Engl J Med."},{"key":"1002_CR36","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/bjh.13610","volume":"171","author":"S Conte","year":"2015","unstructured":"Conte S, Katayama S, Vesterlund L, Karimi M, Dimitriou M, Jansson M, et al. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts. Br J Haematol. 2015;171:478\u201390.","journal-title":"Br J Haematol."},{"key":"1002_CR37","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2018-04-843771","volume":"132","author":"A Pellagatti","year":"2018","unstructured":"Pellagatti A, Armstrong RN, Steeples V, Sharma E, Repapi E, Singh S, et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes\/pathways and clinical associations. Blood 2018;132:1225\u201340.","journal-title":"Blood"},{"key":"1002_CR38","doi-asserted-by":"crossref","first-page":"11.4.1","DOI":"10.1002\/0471250953.bi1114s51","volume":"51","author":"A Dobin","year":"2015","unstructured":"Dobin A, Gingeras TR. Mapping RNA-seq Reads with STAR. Curr Protoc Bioinforma. 2015;51:11.4.1\u20139.","journal-title":"Curr Protoc Bioinforma."},{"key":"1002_CR39","doi-asserted-by":"crossref","unstructured":"Robinson MD, McCarthy Dj Fau - Smyth GK, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26:139\u201340.","DOI":"10.1093\/bioinformatics\/btp616"},{"key":"1002_CR40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33:290\u20135.","journal-title":"Nat Biotechnol."},{"key":"1002_CR41","doi-asserted-by":"crossref","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci USA 2014;111:E5593\u2013601.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1002_CR42","unstructured":"Kolde, R. Pheatmap: pretty heatmaps.\u00a0R Package Version\u00a061, 2012;1\u20137."},{"key":"1002_CR43","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1101\/gr.212696.116","volume":"27","author":"LC Tranchevent","year":"2017","unstructured":"Tranchevent LC, Aube F, Dulaurier L, Benoit-Pilven C, Rey A, Poret A, et al. Identification of protein features encoded by alternative exons using Exon Ontology. Genome Res. 2017;27:1087\u201397.","journal-title":"Genome Res."},{"key":"1002_CR44","volume":"7","author":"S Shen","year":"2016","unstructured":"Shen S, Wang Y, Wang C, Wu YN, Xing Y. SURVIV for survival analysis of mRNA isoform variation. Nat Commun. 2016;7:11548.","journal-title":"Nat Commun."},{"key":"1002_CR45","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1002_CR46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"1002_CR47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajh.23373","volume":"88","author":"MM Patnaik","year":"2013","unstructured":"Patnaik MM, Lasho TL, Finke CM, Hanson CA, Hodnefield JM, Knudson RA, et al. Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance. Am J Hematol. 2013;88:201\u20136.","journal-title":"Am J Hematol."},{"key":"1002_CR48","doi-asserted-by":"crossref","unstructured":"Kotini AG, Chang CJ, Boussaad I, Delrow JJ, Dolezal EK, Nagulapally AB, et al. Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells. Nat Biotechnol. 2015;33:646\u201355.","DOI":"10.1038\/nbt.3178"},{"key":"1002_CR49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng.1031","volume":"44","author":"TA Graubert","year":"2011","unstructured":"Graubert TA, Shen D, Ding L, Okeyo-Owuor T, Lunn CL, Shao J, et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet. 2011;44:53\u20137.","journal-title":"Nat Genet"},{"key":"1002_CR50","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1101\/gad.188037.112","volume":"26","author":"K Yap","year":"2012","unstructured":"Yap K, Lim ZQ, Khandelia P, Friedman B, Makeyev EV. Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention. Genes Dev. 2012;26:1209\u201323.","journal-title":"Genes Dev."},{"key":"1002_CR51","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.devcel.2013.01.015","volume":"24","author":"TC Boothby","year":"2013","unstructured":"Boothby TC, Zipper RS, van der Weele CM, Wolniak SM. Removal of retained introns regulates translation in the rapidly developing gametophyte of Marsilea vestita. Dev Cell 2013;24:517\u201329.","journal-title":"Dev Cell"},{"key":"1002_CR52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cell.2013.06.052","volume":"154","author":"JJ Wong","year":"2013","unstructured":"Wong JJ, Ritchie W, Ebner OA, Selbach M, Wong JW, Huang Y, et al. Orchestrated intron retention regulates normal granulocyte differentiation. Cell 2013;154:583\u201395.","journal-title":"Cell"},{"key":"1002_CR53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1101\/gad.247361.114","volume":"29","author":"PL Boutz","year":"2015","unstructured":"Boutz PL, Bhutkar A, Sharp PA. Detained introns are a novel, widespread class of post-transcriptionally spliced introns. Genes Dev. 2015;29:63\u201380.","journal-title":"Genes Dev."},{"key":"1002_CR54","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1101\/gr.177790.114","volume":"24","author":"U Braunschweig","year":"2014","unstructured":"Braunschweig U, Barbosa-Morais NL, Pan Q, Nachman EN, Alipanahi B, Gonatopoulos-Pournatzis T, et al. Widespread intron retention in mammals functionally tunes transcriptomes. Genome Res. 2014;24:1774\u201386.","journal-title":"Genome Res."},{"key":"1002_CR55","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/nar\/gkv1168","volume":"44","author":"H Pimentel","year":"2016","unstructured":"Pimentel H, Parra M, Gee SL, Mohandas N, Pachter L, Conboy JG. A dynamic intron retention program enriched in RNA processing genes regulates gene expression during terminal erythropoiesis. Nucleic Acids Res. 2016;44:838\u201351.","journal-title":"Nucleic Acids Res."},{"key":"1002_CR56","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1182\/blood-2016-01-692764","volume":"127","author":"CR Edwards","year":"2016","unstructured":"Edwards CR, Ritchie W, Wong JJ, Schmitz U, Middleton R, An X, et al. A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages. Blood 2016;127:e24\u2013e34.","journal-title":"Blood"},{"key":"1002_CR57","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1093\/nar\/gkw591","volume":"44","author":"T Ni","year":"2016","unstructured":"Ni T, Yang W, Han M, Zhang Y, Shen T, Nie H, et al. Global intron retention mediated gene regulation during CD4\u2009+\u2009T cell activation. Nucleic Acids Res. 2016;44:6817\u201329.","journal-title":"Nucleic Acids Res."},{"key":"1002_CR58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrc.2016.51","volume":"16","author":"H Dvinge","year":"2016","unstructured":"Dvinge H, Kim E, Abdel-Wahab O, Bradley RK. RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer 2016;16:413\u201330.","journal-title":"Nat Rev Cancer"},{"key":"1002_CR59","volume":"9","author":"L Shen","year":"2019","unstructured":"Shen L, Zhang J, Lee H, Batista MT, Johnston SA. RNA transcription and splicing errors as a source of cancer frameshift neoantigens for vaccines. Sci Rep. 2019;9:14184.","journal-title":"Sci Rep."},{"key":"1002_CR60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","volume":"34","author":"A Kahles","year":"2018","unstructured":"Kahles A, Lehmann KV, Toussaint NC, Huser M, Stark SG, Sachsenberg T, et al. Comprehensive analysis of alternative splicing across tumors from 8,705 Patients. Cancer Cell 2018;34:211\u201324.e6.","journal-title":"Cancer Cell"},{"key":"1002_CR61","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","volume":"32","author":"M Andreatta","year":"2016","unstructured":"Andreatta M, Nielsen M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics 2016;32:511\u20137.","journal-title":"Bioinformatics"},{"key":"1002_CR62","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen M, Lundegaard C, Worning P, Lauem\u00f8ller SL, Lamberth K, Buus S, et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 2003;12:1007\u201317.","journal-title":"Protein Sci."}],"updated-by":[{"DOI":"10.1038\/s41375-021-01197-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000}}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-1002-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-1002-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-1002-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T19:06:04Z","timestamp":1628017564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-1002-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1038\/s41375-020-1002-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738444959.793578924","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"2 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41375-021-01197-2","URL":"https:\/\/doi.org\/10.1038\/s41375-021-01197-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TH, CH, and WK serve as the management board of the MLL Munich Leukemia Laboratory. NN, ST, SH, MM, WW, and CB are employed by the MLL Munich Leukemia Laboratory. The MLL offers diagnostic services for leukemias and lymphomas, including cytomorphology, cytochemistry, immunophenotyping, cytogenetics, FISH, and a broad spectrum of molecular assays. In addition, MLL runs several research studies based on a combination of methods for routine use and also including whole genome sequencing and whole transcriptome sequencing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}